N-Heterocyclic Carbene Boranes: Dual Reagents for the Synthesis of Gold Nanoparticles.

N-Heterocyclic carbenes (NHCs) have drawn considerable interest in the field of nanomaterials chemistry as highly stabilizing ligands enabling the formation of strong and covalent carbon-metal bonds. Applied to gold nanoparticles synthesis, the most common strategy consists of the reduction of a preformed NHC-AuI complex with a large excess of a reducing agent that makes the particle size difficult to control. In this paper, we report the straightforward synthesis of NHC-coated gold nanoparticles (NHC-AuNPs) by treating a commercially available gold(I) precursor with an easy-to-synthesize NHC-BH3 reagent. The latter acts as both the reducing agent and the source of surface ligands operating under mild conditions. Mechanistic studies including NMR spectroscopy and mass spectrometry demonstrate that the reduction of gold(I) generates NHC-BH2 Cl as a by-product. This strategy gives efficient control over the nucleation and growth of gold particles by varying the NHC-borane/gold(I) ratio, allowing unparalleled particle size variation over the range of 4.9±0.9 to 10.0±2.7 nm. Our strategy also allows an unprecedented precise and controlled seeded growth of gold nanoparticles. In addition, the as-prepared NHC-AuNPs exhibit narrow size distributions without the need for extensive purification or size-selectivity techniques, and are stable over months.

Exploitation of new structurally diverse d-glucuronamide-containing N-glycosyl compounds: synthesis and anticancer potential.

The synthesis and anticancer evaluation of novel N-glycosyl derivatives containing N-substituted glucuronamide moieties, as nucleoside analogs or as prospective mimetics of glycosyl phosphates or of nucleotides, is reported. These compounds comprise N-anomerically-linked nucleobases or motifs that are surrogates of a phosphate group, such as sulfonamide or phosphoramidate moieties. 1-Sulfonamido glucuronamides containing N-benzyl, N-propargyl or N-dodecyl carboxamide units were synthesized through glycosylation of methanesulfonamide with tetra-O-acetyl glucuronamides. 1-Azido glucuronamides were accessed by microwave-assisted reactions of tetra-O-acetyl glucuronamides with TMSN3 and were further converted into N-glycosylphosphoramidates by treatment with trimethyl phosphite. Potential glucuronamide-based nucleotide mimetics comprising both an anomeric sulfonamide/phosphoramidate group and a benzyltriazolylmethyl amide system at C-5, as nucleobase mimetics, were synthesized via 'click' cycloaddition of N-propargyl glucuronamide derivatives with benzyl azide. N-Dodecyl tetra-O-acetyl glucuronamides were converted into uracil and purine nucleosides via N-glycosylation of the corresponding silylated nucleobases. Biological screening revealed significant antiproliferative activities of the N-dodecyl glucuronamide-containing sulfonamide, phosphoramidate and nucleosides in K562 and MCF-7 cells. The highest effect was exhibited by the N9-linked purine nucleoside in the breast cancer cell MCF-7 with a GI50 value similar to that of clinically used 5-fluorouracil. Immunoblotting and cell cycle analysis of K562 cells treated with the most active compound as well as evaluation of the effect of this nucleoside on the activities of caspases 3 and 7 showed induction of apoptosis as the mechanism of cell death.